Matches in SemOpenAlex for { <https://semopenalex.org/work/W2056589553> ?p ?o ?g. }
- W2056589553 endingPage "541" @default.
- W2056589553 startingPage "527" @default.
- W2056589553 abstract "Objective: The conventional liposomal amphotericin B causes many unwanted side effects like blood disorder, nephrotoxicity, dose-dependent side effects, highly variable oral absorption and formulation-related instability. The objective of the present investigation was to develop cost-effective nanoemulsion as nanocarreir for enhanced and sustained delivery of amphotericin B into the skin.Methods and characterizations: Different oil-in-water nanoemulsions were developed by varying the composition of hydrophilic (Tween® 80) surfactants and co-surfactant by the spontaneous titration method. The developed formulation were characterized, optimized, evaluated and compared for the skin permeation with commercial formulation (fungisome 0.01% w/w). Optimized formulations loaded with amphotericin B were screened using varied concentrations of surfactants and co-surfactants as decided by the ternary phase diagram.Results and discussion: The maximum % transmittance obtained were 96.9 ± 1.0%, 95.9 ± 3.0% and 93.7 ± 1.2% for the optimized formulations F-I, F-III and F-VI, respectively. These optimized nanoemulsions were subjected to thermodynamic stability study to get the most stable nanoemulsions (F-I). The results of the particle size and zeta potential value were found to be 67.32 ± 0.8 nm and –3.7 ± 1.2 mV for the final optimized nanoemulsion F-I supporting transparency and stable nanoemulsion for better skin permeation. The steady state transdermal flux for the formulations was observed between 5.89 ± 2.06 and 18.02 ± 4.3 µg/cm2/h whereas the maximum enhancement ratio were found 1.85- and 3.0-fold higher than fungisome and drug solution, respectively, for F-I. The results of the skin deposition study suggests that 231.37 ± 3.6 µg/cm2 drug deposited from optimized nanoemulsion F-I and 2.11-fold higher enhancement ratio as compared to fungisome. Optimized surfactants and co-surfactant combination-mediated transport of the drug through the skin was also tried and the results were shown to have facilitated drug permeation and skin perturbation (SEM).Conclusion: The combined results suggested that amphotericin B nanoemulsion could be a better option for localized topical drug delivery and have greater potential as an effective, efficient and safe approach." @default.
- W2056589553 created "2016-06-24" @default.
- W2056589553 creator A5056798643 @default.
- W2056589553 creator A5061421719 @default.
- W2056589553 creator A5071533103 @default.
- W2056589553 creator A5083508806 @default.
- W2056589553 date "2013-04-29" @default.
- W2056589553 modified "2023-09-26" @default.
- W2056589553 title "Nanocarrier-based topical drug delivery for an antifungal drug" @default.
- W2056589553 cites W1911188526 @default.
- W2056589553 cites W1966939066 @default.
- W2056589553 cites W1970472461 @default.
- W2056589553 cites W1997384329 @default.
- W2056589553 cites W2003661565 @default.
- W2056589553 cites W2008897710 @default.
- W2056589553 cites W2011068615 @default.
- W2056589553 cites W2015684026 @default.
- W2056589553 cites W2022601757 @default.
- W2056589553 cites W2039576398 @default.
- W2056589553 cites W2075970426 @default.
- W2056589553 cites W2079495340 @default.
- W2056589553 cites W2093368848 @default.
- W2056589553 cites W2100520064 @default.
- W2056589553 cites W2107017657 @default.
- W2056589553 cites W2133634376 @default.
- W2056589553 cites W2154862932 @default.
- W2056589553 cites W2168251363 @default.
- W2056589553 cites W2171863529 @default.
- W2056589553 cites W2321438510 @default.
- W2056589553 cites W4238583717 @default.
- W2056589553 cites W4240821889 @default.
- W2056589553 doi "https://doi.org/10.3109/03639045.2013.771647" @default.
- W2056589553 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23627443" @default.
- W2056589553 hasPublicationYear "2013" @default.
- W2056589553 type Work @default.
- W2056589553 sameAs 2056589553 @default.
- W2056589553 citedByCount "36" @default.
- W2056589553 countsByYear W20565895532014 @default.
- W2056589553 countsByYear W20565895532015 @default.
- W2056589553 countsByYear W20565895532016 @default.
- W2056589553 countsByYear W20565895532017 @default.
- W2056589553 countsByYear W20565895532018 @default.
- W2056589553 countsByYear W20565895532019 @default.
- W2056589553 countsByYear W20565895532020 @default.
- W2056589553 countsByYear W20565895532021 @default.
- W2056589553 countsByYear W20565895532022 @default.
- W2056589553 crossrefType "journal-article" @default.
- W2056589553 hasAuthorship W2056589553A5056798643 @default.
- W2056589553 hasAuthorship W2056589553A5061421719 @default.
- W2056589553 hasAuthorship W2056589553A5071533103 @default.
- W2056589553 hasAuthorship W2056589553A5083508806 @default.
- W2056589553 hasConcept C147789679 @default.
- W2056589553 hasConcept C155574463 @default.
- W2056589553 hasConcept C155672457 @default.
- W2056589553 hasConcept C16005928 @default.
- W2056589553 hasConcept C171250308 @default.
- W2056589553 hasConcept C178790620 @default.
- W2056589553 hasConcept C185592680 @default.
- W2056589553 hasConcept C187530423 @default.
- W2056589553 hasConcept C192562407 @default.
- W2056589553 hasConcept C205679159 @default.
- W2056589553 hasConcept C2779548794 @default.
- W2056589553 hasConcept C2779629538 @default.
- W2056589553 hasConcept C2779820397 @default.
- W2056589553 hasConcept C2780035454 @default.
- W2056589553 hasConcept C2991737395 @default.
- W2056589553 hasConcept C41625074 @default.
- W2056589553 hasConcept C43617362 @default.
- W2056589553 hasConcept C50670333 @default.
- W2056589553 hasConcept C55493867 @default.
- W2056589553 hasConcept C58226133 @default.
- W2056589553 hasConcept C71924100 @default.
- W2056589553 hasConcept C86181022 @default.
- W2056589553 hasConcept C98274493 @default.
- W2056589553 hasConceptScore W2056589553C147789679 @default.
- W2056589553 hasConceptScore W2056589553C155574463 @default.
- W2056589553 hasConceptScore W2056589553C155672457 @default.
- W2056589553 hasConceptScore W2056589553C16005928 @default.
- W2056589553 hasConceptScore W2056589553C171250308 @default.
- W2056589553 hasConceptScore W2056589553C178790620 @default.
- W2056589553 hasConceptScore W2056589553C185592680 @default.
- W2056589553 hasConceptScore W2056589553C187530423 @default.
- W2056589553 hasConceptScore W2056589553C192562407 @default.
- W2056589553 hasConceptScore W2056589553C205679159 @default.
- W2056589553 hasConceptScore W2056589553C2779548794 @default.
- W2056589553 hasConceptScore W2056589553C2779629538 @default.
- W2056589553 hasConceptScore W2056589553C2779820397 @default.
- W2056589553 hasConceptScore W2056589553C2780035454 @default.
- W2056589553 hasConceptScore W2056589553C2991737395 @default.
- W2056589553 hasConceptScore W2056589553C41625074 @default.
- W2056589553 hasConceptScore W2056589553C43617362 @default.
- W2056589553 hasConceptScore W2056589553C50670333 @default.
- W2056589553 hasConceptScore W2056589553C55493867 @default.
- W2056589553 hasConceptScore W2056589553C58226133 @default.
- W2056589553 hasConceptScore W2056589553C71924100 @default.
- W2056589553 hasConceptScore W2056589553C86181022 @default.
- W2056589553 hasConceptScore W2056589553C98274493 @default.
- W2056589553 hasIssue "4" @default.